• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EBI, LLC. OSTEOGEN BONE GROWTH STIMULATOR; STIMULATOR, INVASIVE BONE GROWTH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EBI, LLC. OSTEOGEN BONE GROWTH STIMULATOR; STIMULATOR, INVASIVE BONE GROWTH Back to Search Results
Model Number N/A
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/12/2016
Event Type  Injury  
Manufacturer Narrative
Review of device history records show the lot released with no recorded anomaly or deviation.Without a product return, no product evaluation is able to be conducted.Current information is insufficient to permit a valid conclusion about the cause of this event.If additional information is obtained that adds value to the relevant content of this report and/or a conclusion can be drawn, a follow-up report will be sent.
 
Event Description
It was reported during a hip core decompression the bone stimulator was placed into the patient's body.The surgeon was attempting to place the lead where he wanted it when the wire broke off rendering the implant useless.The surgery was completed without using a bone growth stimulator.
 
Manufacturer Narrative
The product was returned for evaluation.The product identity was confirmed through the visual inspection.Based on the evaluation, the product was returned in a plastic bag with the unit cathode broken.The device was tested and found to operate as intended despite the break.The most-likely root cause for the broken titanium wire was determined to be caused by the physician who caused fatigue on the wire until it broke.The cause of the event was determined to be not related to the manufacturing process.
 
Manufacturer Narrative
The titanium wire was sent for further analysis by zimmer biomet warsaw research lab.The analysis confirms the most-likely cause of the titanium wire fracture was overload as the three wires showed ductile overload dimples.The most-likely cause for the overload was determined to be abrupt use by the physician during surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OSTEOGEN BONE GROWTH STIMULATOR
Type of Device
STIMULATOR, INVASIVE BONE GROWTH
Manufacturer (Section D)
EBI, LLC.
399 jefferson road
parsippany NJ 07054
Manufacturer (Section G)
EBI, LLC.
399 jefferson road
parsippany NJ 07054
Manufacturer Contact
michelle cole
399 jefferson road
parsippany, NJ 07054
MDR Report Key5967178
MDR Text Key55273692
Report Number0002242816-2016-00026
Device Sequence Number1
Product Code LOE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PP850035
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 08/23/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/29/2016
Device Model NumberN/A
Device Catalogue Number10-1320
Device Lot Number565-15
Other Device ID NumberN/A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/11/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/23/2016
Initial Date FDA Received09/21/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received10/24/2016
03/23/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/03/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age48 YR
-
-